Role of Novel Microbiological Diagnostics in the Care for Patients with
Cystic Fibrosis
Dřevínek P.1, Fila L.2
Cardiff School of Biosciences, Cardiff University, Park Place, Cardiff, CF10 3TL, Velká Británie1 vedoucí prof. J. Harwood, Ph.D. Pneumologická klinika UK 2. LF a FN Motol, Praha2přednosta doc. MUDr. J. Musil, Ph.D. |
|
Summary:
Patients with cystic fibrosis (CF) are susceptible to chronic respiratory infections
that considerably affect their long-term prognosis. Burkholderia cepacia complex and
Pseudomonas aeruginosa are the most severe pathogens that can cause epidemic outbreaks
within a CF population. To prevent their potential spread, early and reliable diagnostics
along with transmissible strain identification is required.
Molecular genetic methods allow highly sensitive and specific detection of bacteria
belonging to B. cepacia complex and their speciation. Furthermore, the typing techniques
help identify the strains capable of transmission among patients.
The Prague CF Centre has been combating the widespread infection of B. cepacia
complex caused by the strain ST-32 for more than 10 years. The current drop in its incidence
is a likely consequence of strict infection control, which is monitored by applying
molecular microbiological tools.
Key words:
cystic fibrosis, microbiology, diagnostics, Burkholderia cepacia complex,
Pseudomonas aeruginosa, epidemic strain
|